[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.28704512 [View]
File: 47 KB, 951x289, crbp.png [View same] [iqdb] [saucenao] [google]
28704512

>>28703908
>>28704100
>>28703908
Lol he knows literally nothing. Just look at VXRT's price chart for reference on how infallible the institutional researchers are.

Or just zoom out on CRBP, lel. What happened in September?
>Shares of the clinical-stage biotech Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) fell by as much as 77% in pre-market trading Tuesday morning. The drugmaker's shares are tanking this morning in response to a negative late-stage readout for lenabasum in patients with a rare autoimmune disorder known as diffuse cutaneous systemic sclerosis (SSc).

I have also linked to a comprehensive analysis on all of ATOS' pipeline, and none of them looked any good.

Navigation
View posts[+24][+48][+96]